Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Other Non-Current Liabilities (2017 - 2024)

Natural Health Trends' Other Non-Current Liabilities history spans 8 years, with the latest figure at $5.1 million for Q1 2024.

  • For Q1 2024, Other Non-Current Liabilities fell 44.45% year-over-year to $5.1 million; the TTM value through Mar 2024 reached $5.1 million, down 44.45%, while the annual FY2023 figure was $5.1 million, 44.45% down from the prior year.
  • Other Non-Current Liabilities reached $5.1 million in Q1 2024 per NHTC's latest filing, roughly flat from $5.1 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $15.4 million in Q1 2020 to a low of $5.1 million in Q2 2023.
  • Average Other Non-Current Liabilities over 5 years is $10.3 million, with a median of $12.1 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Liabilities: dropped 9.52% in 2020, then plummeted 44.45% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $13.7 million in 2020, then decreased by 11.77% to $12.1 million in 2021, then dropped by 25.0% to $9.1 million in 2022, then tumbled by 44.45% to $5.1 million in 2023, then changed by 0.0% to $5.1 million in 2024.
  • Per Business Quant, the three most recent readings for NHTC's Other Non-Current Liabilities are $5.1 million (Q1 2024), $5.1 million (Q4 2023), and $5.1 million (Q3 2023).